Serial Number 88137747
Registration 6373410
700

Registration Progress

Application Filed
Sep 30, 2018
Under Examination
Apr 2, 2019
Approved for Publication
Feb 5, 2019
Published for Opposition
Feb 5, 2019
Registered
Jun 1, 2021

Trademark Image

Basic Information

Serial Number
88137747
Registration Number
6373410
Filing Date
September 30, 2018
Registration Date
June 1, 2021
Published for Opposition
February 5, 2019
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 1, 2021
Registration
Registered
Classes
044

Rights Holder

Allogene Therapeutics, Inc.

03
Address
210 E. Grand Avenue
South San Francisco, CA 94080

Ownership History

Allogene Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

Allogene Therapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Allogene Therapeutics, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Colleen Ganin

USPTO Deadlines

Next Deadline
687 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-06-01)
Due Date
June 01, 2027
Grace Period Ends
December 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description
Feb 28, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 28, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 28, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 28, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 1, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 28, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 27, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 21, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Apr 21, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 7, 2021 IUAF S USE AMENDMENT FILED
Apr 7, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Apr 6, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2021 EX4G S SOU EXTENSION 4 GRANTED
Apr 2, 2021 EXT4 S SOU EXTENSION 4 FILED
Apr 2, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 22, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 18, 2020 EX3G S SOU EXTENSION 3 GRANTED
Sep 18, 2020 EXT3 S SOU EXTENSION 3 FILED
Sep 18, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 2, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 31, 2020 EX2G S SOU EXTENSION 2 GRANTED
Mar 31, 2020 EXT2 S SOU EXTENSION 2 FILED
Mar 31, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 4, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2019 EX1G S SOU EXTENSION 1 GRANTED
Oct 2, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 2, 2019 EXT1 S SOU EXTENSION 1 FILED
Apr 2, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 5, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 5, 2019 PUBO A PUBLISHED FOR OPPOSITION
Jan 16, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2018 DOCK D ASSIGNED TO EXAMINER
Oct 9, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 8, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 044
Providing medical information to patients and medical professionals in the form of reports in the field of immunotherapy and cancer treatment
First Use Anywhere: Dec 5, 2020
First Use in Commerce: Dec 5, 2020

Additional Information

Design Mark
The mark consists of a dotted circle design.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
044

USPTO Documents

Loading USPTO documents...